These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15357793)

  • 21. Acquired factor V inhibitor in a critically ill patient.
    Morris CJ; Curry N
    Anaesthesia; 2009 Sep; 64(9):1014-7. PubMed ID: 19686488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.
    Wang X; Qin X; Yu Y; Wang R; Liu X; Ji M; Zhou M; Chen C
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):334-341. PubMed ID: 27428013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined factor V and factor VIII deficiency in a Thai patient: a case report of genotype and phenotype characteristics.
    Sirachainan N; Zhang B; Chuansumrit A; Pipe S; Sasanakul W; Ginsburg D
    Haemophilia; 2005 May; 11(3):280-4. PubMed ID: 15876275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in understanding the bleeding diathesis in factor V deficiency.
    Duckers C; Simioni P; Rosing J; Castoldi E
    Br J Haematol; 2009 Jun; 146(1):17-26. PubMed ID: 19438479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma.
    Ahmadinejad M; Roushan N
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):97-9. PubMed ID: 23080366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acquired factor V inhibitors in a polytraumatized patient].
    Tukić L; Stamatović D; Tarabar O; Elez M; Zorić M; Mandić-Radić S
    Vojnosanit Pregl; 2005; 62(7-8):587-90. PubMed ID: 16171024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [You make the diagnosis. Heterozygote factor V deficiency. Venous ectasias in the area of the Kiesselbach locus].
    Zenz W; Muntean W
    Padiatr Padol; 1988; 23(3):253-5. PubMed ID: 3186270
    [No Abstract]   [Full Text] [Related]  

  • 28. Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.
    Emori Y; Sakugawa M; Niiya K; Kiguchi T; Kojima K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Tanimoto M; Yamasaki R; Ohara N; Harada M
    Blood Coagul Fibrinolysis; 2002 Sep; 13(6):555-9. PubMed ID: 12192308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prolonged activated partial thromboplastin time (aPTT): not always indicative of increased risk of bleeding].
    van der Pas AJ; Leebeek FW; Perry DJ; Castel A; van Esser JW
    Ned Tijdschr Geneeskd; 2009; 153():B42. PubMed ID: 19785809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acquired factor V inhibitor].
    Yamada S; Asakura H
    Rinsho Ketsueki; 2020; 61(7):791-798. PubMed ID: 32759567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy.
    Takahashi H; Fuse I; Abe T; Yoshino N; Aizawa Y
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):87-93. PubMed ID: 12544735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
    Wiwanitkit V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired inhibitors to the coagulation factor XII associated with liver disease.
    Chalkiadakis G; Kyriakou D; Oekonomaki E; Tsiaoussis J; Alexandrakis M; Vasilakis S; Kouroumalis E
    Am J Gastroenterol; 1999 Sep; 94(9):2551-3. PubMed ID: 10484024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Off-pump coronary artery bypass grafting in a patient with congenital factor V deficiency: report of a case.
    Yotsumoto G; Masuda H; Toyokawa K; Iguro Y; Kinjo T; Sakata R
    Surg Today; 2005; 35(2):142-4. PubMed ID: 15674496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of acquired factor X inhibitor by plasma exchange with concomitant intravenous immunoglobulin and corticosteroids.
    Hsia CC; Keeney M; Bosco AA; Xenocostas A
    Am J Hematol; 2008 Apr; 83(4):318-20. PubMed ID: 17975806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parahemophilia. Factor V deficiency.
    Seeler RA
    Med Clin North Am; 1972 Jan; 56(1):119-25. PubMed ID: 4550185
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
    Peng L; Yan C; Wu X; Nie L
    Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propylthiouracil-related hemorrhagic diathesis: a case report and review of the literature.
    Akarsu E; Buyukhatipoglu H; Aktaran S; Geyik R
    Mt Sinai J Med; 2006 Nov; 73(7):1021-3. PubMed ID: 17195890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemorrhagic varicella in parahemophilia.
    Girolami A; Scarpa R; Cadrobbi P
    Blut; 1972 Nov; 25(5):293-301. PubMed ID: 4637913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.